Examination of Immunosuppression Adjustment Impact on Kidney Function in Liver Transplant

NCT04104438 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

71

Enrollment

OTHER

Sponsor class

Conditions

Asses Immunosuppression Modulation on Renal Recovery Post LT

Interventions

DRUG: Basiliximab 20 MG

Sponsor

Fady M Kaldas, M.D., F.A.C.S.